TEXAS Instruments (TI) said on Tuesday (Aug 20) that its free cash flow (FCF) would jump in 2026 as demand rebounds and the analogue chipmaker tightens capital spending after pressure from activist investor Elliott Investment Management.
The company has been building out its manufacturing capacity to prevent chip shortages such as those seen during the pandemic and address future demand, a move that drew investor scrutiny as expenses weighed on cash flow.
The chipmaker expects FCF per share to be between US$8 and US$12 in 2026, higher than an estimate of US$6.91, according to Visible Alpha. It had fallen 77 per cent to US$1.47 in 2023, LSEG data showed.
Elliott, which in May disclosed a US$2.5 billion stake, had pushed TI to tighten spending and adjust its production capacity to the changes in demand, arguing the strategy could improve FCF to US$9 per share by 2026.
The activist investor said on Tuesday’s announcements, made at an off-cycle capital allocation event, were a “positive step” towards improving value for the company’s shareholders.
TI has been bringing more production in-house and expanding its 300 mm production capacity due to its cost-effectiveness.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
CEO Haviv Ilan attributed the FCF growth to the structure of its 300 mm production capacity expansion. The initial stages of the transition will be completed in 2026, allowing it to phase out investments.
TI, which expects revenue between US$20 billion to US$26 billion for 2026, said capital expenditure for the year is estimated to be between US$2 billion and US$5 billion, compared with its initial plans to spend about US$5 billion a year to 2026.
“This is a welcome announcement and not a total surprise as there were hints that TI’s grand capital expenditure plans would tighten,” said Michael Schulman, chief investment officer at Running Point Capital.
TI is also set to receive up to US$1.6 billion for building new facilities under the US Chips and Science Act. REUTERS